X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (917) 917
Publication (88) 88
Book Chapter (11) 11
Book Review (5) 5
Conference Proceeding (2) 2
Book / eBook (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (712) 712
male (404) 404
middle aged (325) 325
aged (302) 302
female (281) 281
index medicus (256) 256
hematology (240) 240
waldenstrom macroglobulinemia - complications (184) 184
adult (177) 177
waldenstrom macroglobulinemia - drug therapy (144) 144
waldenstrom macroglobulinemia - diagnosis (143) 143
waldenstrom macroglobulinemia - immunology (141) 141
waldenstrom macroglobulinemia - pathology (130) 130
waldenstrom macroglobulinemia (128) 128
rituximab (99) 99
oncology (93) 93
aged, 80 and over (91) 91
waldenstrom macroglobulinemia - blood (91) 91
lymphomas (87) 87
immunoglobulin m (78) 78
lymphoma (76) 76
waldenstrom macroglobulinemia - genetics (76) 76
waldenstrom's macroglobulinaemia (76) 76
macroglobulinemia (74) 74
prognosis (68) 68
waldenstroms macroglobulinemia (68) 68
waldenstrom macroglobulinemia - therapy (67) 67
immunoglobulin m - analysis (66) 66
treatment outcome (66) 66
multiple myeloma (65) 65
diagnosis (64) 64
therapy (64) 64
multiple-myeloma (63) 63
lymphoplasmacytic lymphoma (61) 61
waldenstrom macroglobulinaemia (61) 61
chronic lymphocytic-leukemia (60) 60
waldenström macroglobulinaemia (60) 60
monoclonal gammopathy (57) 57
mutation (56) 56
waldenström's macroglobulinaemia (52) 52
waldenstrom's macroglobulinemia (50) 50
immunoglobulin m - blood (49) 49
consensus panel recommendations (48) 48
immunoglobulins (48) 48
pathology (47) 47
diagnosis, differential (46) 46
2nd international workshop (45) 45
retrospective studies (45) 45
waldenström macroglobulinemia (45) 45
care and treatment (43) 43
multiple myeloma - immunology (42) 42
survival (40) 40
cancer (39) 39
myd88 (39) 39
waldenstrom macroglobulinemia - mortality (39) 39
antineoplastic agents - therapeutic use (38) 38
hemic and lymphatic diseases (38) 38
igm monoclonal gammopathy (38) 38
waldenström's macroglobulinemia (38) 38
animals (37) 37
bone marrow (37) 37
bone marrow - pathology (37) 37
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
immunoelectrophoresis (35) 35
medicine & public health (35) 35
medicine, general & internal (35) 35
myd88 l265p (34) 34
chemotherapy (33) 33
leukemia (33) 33
patients (33) 33
clinical neurology (32) 32
immunoglobulin m - immunology (32) 32
research article (32) 32
analysis (31) 31
blood viscosity (31) 31
immunoglobulin g - analysis (31) 31
immunology (31) 31
multiple myeloma - blood (31) 31
myeloid differentiation factor 88 - genetics (31) 31
biopsy (30) 30
fludarabine (30) 30
waldenstrom macroglobulinemia - metabolism (30) 30
disease (29) 29
ibrutinib (29) 29
immunoglobulin m - metabolism (29) 29
myeloma (29) 29
risk factors (29) 29
serum globulins (29) 29
undetermined significance (29) 29
international workshop (28) 28
peripheral neuropathy (28) 28
survival analysis (28) 28
bortezomib (27) 27
l265p somatic mutation (27) 27
follow-up studies (26) 26
immunoglobulin g (26) 26
research (26) 26
waldenstrom macroglobulinemia - epidemiology (26) 26
waldenstrom macroglobulinemia - physiopathology (26) 26
igm (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (869) 869
French (19) 19
German (9) 9
Hungarian (8) 8
Czech (6) 6
Portuguese (5) 5
Japanese (3) 3
Chinese (2) 2
Danish (2) 2
Dutch (2) 2
Italian (2) 2
Croatian (1) 1
Norwegian (1) 1
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2016, Volume 172, Issue 5, pp. 735 - 744
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 2, pp. 241 - 250
Journal Article
La Revue du praticien, ISSN 0035-2640, 09/2018, Volume 68, Issue 7, p. 797
Waldenström macroglobulinaemia. Waldenström macroglobulinaemia (WM) is a rare, indolent B-cell lymphoproliferative disorder characterized by cellular... 
Rituximab - therapeutic use | Waldenstrom Macroglobulinemia - drug therapy | Humans | Neoplasm Recurrence, Local | Antibodies, Monoclonal - therapeutic use | Cyclophosphamide - therapeutic use
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2017, Volume 177, Issue 5, pp. 669 - 671
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2015, Volume 168, Issue 5, pp. 701 - 707
Summary CXCR4WHIM frameshift and nonsense mutations follow MYD88L265P as the most common somatic variants in Waldenström Macroglobulinaemia (WM), and impact... 
ibrutinib | CXCR4 | Waldenström macroglobulinaemia | WHIM | MYD88 | Ibrutinib
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2017, Volume 179, Issue 3, pp. 439 - 448
Summary Histological transformation (HT) to diffuse large B‐cell lymphoma (DLBCL) is a rare and poorly reported complication of Waldenström macroglobulinaemia... 
chemoimmunotherapy | extranodal involvement | diffuse large B‐cell lymphoma | Waldenström macroglobulinaemia | histological transformation | diffuse large B-cell lymphoma | LYMPHOPLASMACYTIC LYMPHOMA | IMMUNOBLASTIC SARCOMA | CHEMOTHERAPY | TRANSPLANTATION | Waldenstrom macroglobulinaemia | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | MUTATIONS | HEMATOLOGY | CHLORAMBUCIL | MYD88 | Doxorubicin - therapeutic use | Prognosis | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Cyclophosphamide - therapeutic use | Waldenstrom Macroglobulinemia - pathology | Lymphoma, Large B-Cell, Diffuse - diagnostic imaging | Aged, 80 and over | Waldenstrom Macroglobulinemia - diagnostic imaging | Adult | Female | Retrospective Studies | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Factors | Treatment Outcome | Positron-Emission Tomography - methods | Biomarkers, Tumor - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Biopsy | L-Lactate Dehydrogenase - blood | Survival Analysis | Vincristine - therapeutic use | Fluorodeoxyglucose F18 | Aged | Cell Transformation, Neoplastic - pathology | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | PET imaging | Leukemia | Leptin | Oncology, Experimental | Lymphomas | Research | Health aspects | Cancer | Transformation | Emission analysis | Medical services | Central nervous system | Positron emission | Rituximab | Prednisone | Lymphoma | Patients | Doxorubicin | Vincristine | Cyclophosphamide | Lymphocytes B | Positron emission tomography | B-cell lymphoma | Index Medicus | Life Sciences | Hematology | Human health and pathology
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2018, Volume 180, Issue 3, pp. 374 - 380
Summary MYD88 mutations are present in 95% of Waldenstrom Macroglobulinaemia (WM) patients, and support diagnostic discrimination from other IgM‐secreting... 
Waldenström Macroglobulinaemia | overall survival | transformation | IgM myeloma | MYD88 | Patient outcomes | Multiple myeloma | Diagnosis
Journal Article